Literature DB >> 19332638

Quantitative abnormalities of peripheral blood distinct T, B, and natural killer cell subsets and clinical findings in obstetric antiphospholipid syndrome.

Javier Carbone1, Antonio Gallego, Nallibe Lanio, Joaquin Navarro, Maria Orera, Angel Aguaron, Eduardo Fernandez-Cruz, Elizabeth Sarmiento.   

Abstract

OBJECTIVE: Few studies have assessed immunophenotypic abnormalities on lymphocyte subsets in patients with antiphospholipid syndrome (APS). We performed an extended immunological study to define alterations of distinct T, B, and natural killer (NK) cell subsets in obstetric patients with APS and their relationship with APS-associated complications. PATIENTS AND CONTROLS: 36 women with APS [Sydney criteria, Group A1 without thrombosis (n=26), Group A2 with thrombosis (n=10)]; and 36 age matched women with recurrent abortion without antiphospholipid antibodies (disease controls; Group B), 36 healthy parous women (healthy controls; Group C), and 36 healthy nonparous women (healthy controls; Group D). Thrombotic events occurred after history of abortions in all A2 women. Three-color whole-blood flow cytometry was used to characterize the distinct immunophenotypes.
RESULTS: A1 patients had significantly higher percentages of CD4+CD45RA-CCR7+ central memory cells (A1 vs D), higher percentages of activated CD4+CD25+ T cells (A1 vs D), and lower percentages and absolute counts of CD4+CD45RA-CCR7- effector memory cells (A1 vs D). Group A2 patients had higher percentages and absolute numbers of CD19+CD27-IgD+ naive B cells (A2 vs A1 vs all controls), lower percentages and absolute numbers of CD3-CD56+CD16+ NK cells (A2 vs all controls), and higher percentages of activated CD4+DR+ (A2 vs all controls), CD8+DR+ (A2 vs A1 vs C vs D), CD4+CD38+DR+ (A2 vs D), and CD4+CD25+DR+ T cells (A2 vs all controls). Increased percentages of CD8+DR+ T cells [relative risk (RR) 2.43, 95% CI 1.09-5.44, p=0.02] and of naive B cells (RR 3.05, 95% CI 1.30-7.11, p=0.009) were associated with development of thrombosis.
CONCLUSION: In obstetric patients with APS we documented significant changes in T, B, and NK cell homeostasis. Increased levels of CD8+DR+ and CD19+CD27-IgD+ cells might identify obstetric patients with APS at risk of having thrombosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332638     DOI: 10.3899/jrheum.081079

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases.

Authors:  Mario Ojeda-Uribe; Naji Afif; Etienne Dahan; Laetitia Sparsa; Celine Haby; Jean Sibilia; David Ternant; Marc Ardizzone
Journal:  Clin Rheumatol       Date:  2013-01-05       Impact factor: 2.980

2.  Preliminary Study on the Imbalance Between Th17 and Regulatory T Cells in Antiphospholipid Syndrome.

Authors:  Huanhuan Yan; Baochen Li; Rui Su; Chong Gao; Xiaofeng Li; Caihong Wang
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

Review 3.  Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up.

Authors:  Laurent Simonin; Elisabeth Pasquier; Christophe Leroyer; Divi Cornec; Julie Lemerle; Boutahar Bendaoud; Sophie Hillion; Jacques-Olivier Pers; Francis Couturaud; Yves Renaudineau
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

Review 4.  To B or not to B cells-mediate a healthy start to life.

Authors:  T G Nguyen; C M Ward; J M Morris
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

5.  CD8+DR+ T-Cells and C3 Complement Serum Concentration as Potential Biomarkers in Thrombotic Antiphospholipid Syndrome.

Authors:  Elizabeth Sarmiento; Jonathan Dale; Mauricio Arraya; Antonio Gallego; Nallibe Lanio; Joaquin Navarro; Javier Carbone
Journal:  Autoimmune Dis       Date:  2014-05-29

6.  Peripheral B-Cell Subset Distribution in Primary Antiphospholipid Syndrome.

Authors:  Lorena Alvarez-Rodriguez; Leyre Riancho-Zarrabeitia; Jime Calvo-Alén; Marcos López-Hoyos; Victor Martínez-Taboada
Journal:  Int J Mol Sci       Date:  2018-02-16       Impact factor: 5.923

7.  The Role of PPARs in Placental Immunology: A Systematic Review of the Literature.

Authors:  Stefan Hutter; Julia Knabl; Ulrich Andergassen; Udo Jeschke
Journal:  PPAR Res       Date:  2013-03-10       Impact factor: 4.964

8.  T Cell Dysregulation in Non-silicotic Silica Exposed Workers: A Step Toward Immune Tolerance Breakdown.

Authors:  Benoit Brilland; Céline Beauvillain; Gery Mazurkiewicz; Pierre Rucay; Yves Roquelaure; Julie Tabiasco; Emeline Vinatier; Jérémie Riou; Pascale Jeannin; Gilles Renier; Jean-François Subra; Jean-François Augusto
Journal:  Front Immunol       Date:  2019-11-22       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.